Gilliland Jeter Wealth Management LLC 89bio, Inc. Transaction History
Gilliland Jeter Wealth Management LLC
- $307 Billion
- Q2 2025
A detailed history of Gilliland Jeter Wealth Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Gilliland Jeter Wealth Management LLC holds 52,749 shares of ETNB stock, worth $506,917. This represents 0.17% of its overall portfolio holdings.
Number of Shares
52,749
Previous 48,879
7.92%
Holding current value
$506,917
Previous $355 Million
45.77%
% of portfolio
0.17%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding ETNB
# of Institutions
207Shares Held
160MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$197 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$191 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$138 Million4.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$89.5 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$68.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $447M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...